CDC PrEP Push: Could Daily Pill Help Curb HIV in North Dakota?

Why it matters locally: The CDC's renewed emphasis on PrEP (pre-exposure prophylaxis) as an HIV prevention tool has important implications for North Dakota. While North Dakota's overall HIV rates might be lower than in more densely populated states, access to healthcare, particularly preventative care, can be challenging in rural areas. Increased awareness of PrEP and its availability could significantly reduce new HIV infections within the state, especially among at-risk populations who might currently face barriers to testing and treatment. Expanding access to PrEP requires increased education for both residents and healthcare providers across North Dakota.

---

Atlanta, GA – The Centers for Disease Control and Prevention (CDC) is focusing attention on the role of daily oral pre-exposure prophylaxis (PrEP) as a method for preventing HIV transmission. Information released by the agency underscores the potential impact of PrEP when taken as prescribed. PrEP involves taking a daily pill, which contains anti-HIV medications, to significantly reduce the risk of HIV infection. The CDC emphasizes that its effectiveness hinges on consistent and correct usage. The CDC's information indicates a persistent gap between the number of individuals who could benefit from PrEP and the number who are currently prescribed it. This disparity highlights a need for increased awareness among both at-risk populations and healthcare providers. Expanding education efforts and access to PrEP could contribute to reducing new HIV infections, according to the agency. The CDC recommends discussing PrEP with a healthcare provider to determine if it is appropriate for individuals at risk for HIV. Further information, including guidelines for prescribing PrEP and resources for finding local providers, can be found on the CDC’s website.